2018 NATIONAL OPAT CONFERENCE 13-14 DECEMBER 2018, THE ICC, BIRMINGHAM DELEGATE BROCHURE #OPAT18
SCIENTIFIC PROGRAMME - 13 DECEMBER 2017 13 DECEMBER 2018 0930 Welcome and Opening Remarks SESSION ONE: CAN I TELL YOU A STORY? Chair, Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children s Hospital 0940 My OPAT journey - a younger person s perspective, Question and Answer session Mr Thomas Mallet, Young person, Southampton Children s Hospital OPAT service patient in 2017 SESSION TWO: OPAT CHALLENGES IN SPECIFIC CONDITIONS 1015 OPAT via telemedicine (Presentation via Skype) Dr Paul Ingram - PathWest, Royal Perth Hospital, Fiona Stanley Hospital, Western Australia 1030 Defining the positive outcome - OPAT in palliative care Dr Eoghan de Barra, Senior Consultant, RCSI Tropical Medicine, Royal College of Surgeons in Ireland, Dublin 1045 Managing Staphylococcal Bacteraemias Dr Claire Mackintosh, Consultant Infectious Disease Physician, Regional Infectious Diseases Unit, Western General Hospital Edinburgh 1100 The challenge of orthopaedic infections in the post OVIVA era Dr Bridget Atkins, Consultant in Microbiology and Infectious Diseases, Oxford University Hospitals NHS FT 1100 Selected from abstracts 1130 REFRESHMENTS AND NETWORKING SESSION THREE: DELIVERING SAFER OPAT 1200 Good Practice Recommendations - the key learning points Dr Ann Chapman, Consultant Infectious Disease and General Medicine,NHS Lanarkshire 1215 Using OPAT to drive paediatric stewardship Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children s Hospital 1235 Beyond the OPAT MDT: hazards and opportunities Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine & Antimicrobial Management Team Lead NHS GGC, Queen Elizabeth University Hospital, Glasgow
SCIENTIFIC PROGRAMME - 13 DECEMBER 2017 DEBATE: OPAT COMPETENCIES - NEEDED OR NOT? 1255 Speaking in favour Dr Sue Snape, Lead OPAT Consultant, Nottingham University Hospitals NHS Trust 1305 Speaking against Dr Sarah Logan, Consultant In infectious disease and General medicine, Hospital for Tropical Diseases at UCLH SESSION FOUR: SUPPORTED SESSION 1315 Cardiome 1400 LUNCH AND POSTER VIEWING SESSION FIVE: DRUGS & DEVICES 1500 Outpatient management of complex oral antibiotic regimens Julie Statham, Principal Pharmacist for Infection, South Warwickshire NHS Foundation Trust 1515 ECG directed PICC line insertion Mrs Liz Wilson, OPAT Lead Nurse, Wythenshawe Hospital, Manchester University Foundation NHS Trust 1530 Vascular health management in children 1545 Selected from abstracts 1600 Selected from abstracts 1615 REFRESHMENTS AND NETWORKING SESSION SIX: LESSONS AND DILEMMAS FROM THE REGIONS 1645 Setting up an in house elastomeric device service for OPAT Dr Sue Snape, Lead OPAT Consultant, Nottingham University Hospitals NHS Trust 1700 Role of OPAT in hemodialysis Dr Carolyn Hemsley, Microbiology and Infectious Disease Consultant, Department of Infection, Guy s and St Thomas NHS Foundation Trust, London 1715 Vascular graft infection and OPAT Dr Fiona Andrewartha, OPAT Consultant, Nottingham 1730 Tubo-ovarian abscess and OPAT Dr James Hatcher, Imperial College Healthcare NHS Trust 1745 Nurse led management of SSTIs Ms Claire Vallance, Queens Elizabeth University Hospital, Glasgow
SCIENTIFIC PROGRAMME - 14 DECEMBER 2017 SESSION SEVEN: NATIONAL DISCUSSION FORUM 1800 Facilitated discussion addressing issues raised by delegates 1845 Welcome drinks, networking and poster presentations 14 DECEMBER 2018 0730 Breakfast refreshments SESSION EIGHT: INTERACTIVE CLINICAL CASE STUDIES 0800 Case study 1 Dr Chris Lynch, Nottingham 0815 Case study 2 Dr Chris Lynch, Nottingham 0830 Case study 3 Dr Hector Maxwell-Scott, Infectious Diseases / Microbiology Registrar, Guys & St Thomas Hospital, London 0845 Case study 4 Dr Anna Goodman, Guys & St Thomas Hospital, London 0900 Expert panel discussion SESSION NINE: SPONSORED SESSION 0915 Baxter 1030 REFRESHMENTS AND NETWORKING SESSION TEN: KEYNOTE LECTURE 1100 Role of extended dosing interval antimicrobials in OPAT Dr Urania Rappo, Director, Clinical Development (Anti-Infectives), Allergan 1130 Q&A
SCIENTIFIC PROGRAMME - 14 DECEMBER 2017 SESSION ELEVEN: INVITED PAPERS 1145 Selected from abstracts 1200 Selected from abstracts 1215 Selected from abstracts 1230 Selected from abstracts SESSION TWELVE: INFORMING THE FUTURE AGENDA 1245 Measuring practice and outcomes - Registry outputs and what they mean 1300 UK Drug Stability Testing Programme - outputs and future aspirations Dr Conor Jamieson, Pharmacy Team Leader Antimicrobial Therapy, Sandwell and West Birmingham NHS Trust 1315 OPAT 2019 and beyond 1330 Close